These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 6214262)

  • 21. In vitro investigations on the action fosfomycin alone and in combination with other antibiotics on Pseudomonas aeruginosa and Serratia marcescens.
    Ullmann U; Lindemann B
    Arzneimittelforschung; 1980; 30(8):1247-9. PubMed ID: 6776966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activities of new beta-lactam antibiotics against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
    Prince AS; Neu HC
    Antimicrob Agents Chemother; 1981 Oct; 20(4):545-6. PubMed ID: 6282199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibilities of anaerobic bacteria to N-formimidoyl thienamycin (MK0787) and to other antibiotics.
    Kesado T; Watanabe K; Asahi Y; Isono M; Ueno K
    Antimicrob Agents Chemother; 1982 Jun; 21(6):1016-22. PubMed ID: 6956247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Gram-negative rods: antibacterial agents effective on gram-negative rods].
    Iyobe S
    Nihon Rinsho; 1994 Feb; 52(2):372-7. PubMed ID: 8126888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activity of N-formimidoyl thienamycin and cephalosporins against isolates from nosocomially acquired bacteremia.
    Gutiérrez-Núñez J; Harrington PT; Ramirez-Ronda CH
    Antimicrob Agents Chemother; 1982 Mar; 21(3):509-12. PubMed ID: 6954876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-vitro activity of MK0787 (N-formimidoyl thienamycin) against Pseudomonas aeruginosa and other Gram-negative organisms and its stability to their beta-lactamases.
    Livermore DM; Williams RJ; Williams JD
    J Antimicrob Chemother; 1981 Nov; 8(5):355-62. PubMed ID: 6798011
    [No Abstract]   [Full Text] [Related]  

  • 27. Antibacterial activities of a new stabilized thienamycin, N-formimidoyl thienamycin, in comparison with other antibiotics.
    Kesado T; Hashizume T; Asahi Y
    Antimicrob Agents Chemother; 1980 Jun; 17(6):912-7. PubMed ID: 6931548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of piperacillin compared with that of ampicillin, ticarcillin, azlocillin, and mezlocillin.
    Machka K; Dickert H; Braveny I
    Arzneimittelforschung; 1980; 30(2):304-7. PubMed ID: 6445735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [On the combination of clindamycin with beta-lactam antibiotics and aminoglycosides (author's transl)].
    Adam D; Nawrath I
    Arzneimittelforschung; 1981; 31(8):1295-8. PubMed ID: 7197536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of piperacillin and other microbials on 491 bacterial isolates.
    Reeves DS
    Arch Intern Med; 1982 Oct; 142(11):2023-32. PubMed ID: 6215009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ciprofloxacin in combination with other antimicrobial substances].
    Shah PM; Mellinghoff D; Stille W
    Arzneimittelforschung; 1988 Mar; 38(3):411-5. PubMed ID: 3164186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities.
    Kropp H; Sundelof JG; Kahan JS; Kahan FM; Birnbaum J
    Antimicrob Agents Chemother; 1980 Jun; 17(6):993-1000. PubMed ID: 6931549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simple method to determine beta-lactam resistance phenotypes in Pseudomonas aeruginosa using the disc agar diffusion test.
    Vedel G
    J Antimicrob Chemother; 2005 Oct; 56(4):657-64. PubMed ID: 16144872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of newer beta-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens.
    Meyer RD; Pasiecznik K
    Diagn Microbiol Infect Dis; 1983 Dec; 1(4):287-93. PubMed ID: 6321092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro comparison of N-formimidoyl thienamycin (MK0787) and Azlocillin with three aminoglycosides and ticarcillin against Pseudomonas aeruginosa.
    Matzkowitz AJ; Baltch AL; Smith RP; Sutphen NT; Hammer MC; Conroy JV
    Antimicrob Agents Chemother; 1982 Apr; 21(4):685-7. PubMed ID: 6805426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-formimidoyl thienamycin (MK0787): in vitro study.
    Shadomy S; May RS
    Antimicrob Agents Chemother; 1981 Jan; 19(1):201-4. PubMed ID: 6941741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of N-formimidoyl-thienamycin in comparison to that of moxalactam and cefotaxime against gentamicin-resistant gram-negative bacteria.
    Pusztai-Markos Z; Pranada F
    Eur J Clin Microbiol; 1982 Feb; 1(1):49-51. PubMed ID: 6293811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity of N-formimidoyl thienamycin (MK0787), a crystalline derivative of thienamycin.
    Horadam VW; Smilack JD; Montgomery CL; Werringloer J
    Antimicrob Agents Chemother; 1980 Oct; 18(4):557-61. PubMed ID: 6934707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The morphological response of Pseudomonas aeruginosa to azthreonam, cefoperazone, ceftazidime and N-formimidoyl thienamycin.
    Elliott TS; Greenwood D
    J Med Microbiol; 1984 Apr; 17(2):159-69. PubMed ID: 6423826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitivity of 341 non-fermentative gram-negative bacteria to seven beta-lactam antibiotics.
    Appelbaum PC; Tamim J; Stavitz J; Aber RC; Pankuch GA
    Eur J Clin Microbiol; 1982 Jun; 1(3):159-65. PubMed ID: 7173181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.